Coherus Oncology Inc (CHRS)

Stock-Based Compensation

$21.54M

TTM · Period ending: · USD

CHRS logo

CHRS Stock-Based Compensation

Latest reported$21.54M
CHRS Stock-Based Comp ($443.00K → $21.54M)
High-resolution chart · PNG

CHRS stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
16,966,000
27,802,000
43,110,000
50,737,000
51,364,000
38,160,000
33,591,000
34,797,000
36,065,000
27,421,000
16,721,000
11,062,000
2,045,000
443,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.